Cited by

• Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice.

  Wu ML, Liu FL, Sun J, Li X, Qin JR, Yan QH, Jin X, Chen XW, Zheng YT, Zhao JC, Wang JH. Wu ML, et al. Zool Res. 2022 May 18;43(3):457-468. doi: 10.24272/j.issn.2095-8137.2021.469. Zool Res. 2022. PMID: 35503561 Free PMC article.
• Molnupiravir in COVID-19: A systematic review of literature.

  Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102329. doi: 10.1016/j.dsx.2021.102329. Epub 2021 Oct 30. Diabetes Metab Syndr. 2021. PMID: 34742052 Free PMC article.
• Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review.

  Jain NK, Tailang M, Jain HK, Chandrasekaran B, Sahoo BM, Subramanian A, Thangavel N, Aldahish A, Chidambaram K, Alagusundaram M, Kumar S, Selvam P. Jain NK, et al. Front Pharmacol. 2023 Mar 20;14:1135145. doi: 10.3389/fphar.2023.1135145. eCollection 2023. Front Pharmacol. 2023. PMID: 37021053 Free PMC article. Review.
• Modulation of in Vitro SARS-CoV-2 Infection by Stephania tetrandra and Its Alkaloid Constituents.

  Khadilkar A, Bunch ZL, Wagoner J, Ravindran V, Oda JM, Vidar WS, Clark TN, Manwill PK, Todd DA, Barr SA, Olinger LK, Fink SL, Strangman WK, Linington RG, MacMillan JB, Cech NB, Polyak SJ. Khadilkar A, et al. J Nat Prod. 2023 Apr 28;86(4):1061-1073. doi: 10.1021/acs.jnatprod.3c00159. Epub 2023 Apr 12. J Nat Prod. 2023. PMID: 37043739 Free PMC article.
• Post-COVID Interstitial Lung Disease-The Tip of the Iceberg.

  Kewalramani N, Heenan KM, McKeegan D, Chaudhuri N. Kewalramani N, et al. Immunol Allergy Clin North Am. 2023 May;43(2):389-410. doi: 10.1016/j.iac.2023.01.004. Epub 2023 Mar 3. Immunol Allergy Clin North Am. 2023. PMID: 37055095 Free PMC article. Review.